Evaluating the contribution of allogeneic and autologous transplantation to the management of acute myeloid leukemia in adults

Cancer Chemotherapy and Pharmacology

Volumn 48, Issue SUPPL. 1, 2001, Pages

  Burnett, Alan K ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Acute myelogenous leukemia; Acute myeloid leukemia; Allograft; Autograft; Transplant

Indexed keywords

ALLOTRANSPLANTATION; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; HUMAN; METHODOLOGY; MULTIMODALITY CANCER THERAPY; MYELOID LEUKEMIA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; HUMANS; LEUKEMIA, MYELOID; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0002089574     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800100306     Document Type: Review

References (21)

1. Amadori S, Testi AM, Arico M, Comelli A, Giulianco M, Madon E, Masera G, Rondelli R, Zanesco L, Mandelli F (1993) Prospective comparative study of bone marrow transplantation and post-remission chemotherapy for childhood acute myelogenous leukemia. J Clin Oncol 11:1046
2. Burnett AK (2001) Treatment of AML in younger patients. Baillieres Clin Haematol 14: (in press)
3. Burnett AK, Tansey P, Watkins R, Alcorn M, Maharaj D, Singer CR, McKinnon S, McDonald GA, Robertson AG (1984) Transplantation of unpurged autologous bone marrow in acute myeloid leukemia in first remission. Lancet 2:1068
4. Burnett AK, Goldstone AH, Stevens R, Hann IM, Rees JK, Gray RG, Wheatley K (1998) Randomised comparison of addition of autologous bone-marrow transplantation in intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 Trial. Lancet 351:700
5. Cassileth PA, Harrington DP, Appelbaum F, Lazarus HM, Rowe JM, Paietta E, Willman C, Hurd DD, Bennett JM, Blume KG, Head DR, Wiernick PH (1998) Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med 339:1649
6. Goldstone AH, Anderson CC, Linch DC, Franklin IM, Boughton BJ, Cawley JC, Richards JD (1986) Autologous bone marrow transplantation following high dose therapy for the treatment of adult patients with acute myeloid leukaemia. Br J Haematol 64:529
7. Gorin NC, Labopin M, Meloni G, Korbling M, Carella A, Herve P, Burnett AK, Rizzoli V, Alessandrino EP, Bjorkstrand B, Ferrant A, Lowenberg B, Coser P, Simonsson B, Helbig W, Brunet Mauri S, Verdonk LF, Iriondo A, Polli E, Colombat P, Franklin IM, Souillet G, Willemze R (1997) Autologous bone marrow transplantation for acute myeloid leukemia in Europe: further evidence of the role of marrow purging by masfosfamide. Leukemia 5:896
8. Gray R, Wheatley K (1991) How to avoid bias when comparing bone marrow transplantation with chemotherapy. Bone Marrow Transplant 7 [Suppl 3]:9
9. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 Trial. Blood 92:2322
10. Harousseau JL, Cahn JY, Pignon B, Witz F, Milpied N, Delain M, Lioure B, Lamy T, Desablens B, Guilhot F, Caillot D, Abgrall JF, Froncois S, Briere J, Guyotat D, Casassus P, Audhuy B, Tellier Z, Hurtleoup P, Herve P (1997) Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. Blood 90:2978
11. Keating S, de Witte T, Suciu S, Willemze R, Hayat M, Labar B, Resegotti L, Ferrini PR, Caronia F, Dardenne M, Solbu G, Petti MC, Vegna ML, Mandelli F, Zittoun RA (1998) The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. Br J Haematol 102:1344
12. Lowenberg B, Verdonck LJ, Dekker A, Willemze R, Zwaan FE, de Planque M, Abels J, Sonneveld P, van der Lelie J, Goudsmit R, Vanputten WLJ, Sizoo W, Hagenbeek A, Degast GC (1990) Autologous bone marrow transplantation in acute myeloid leukemia in first remission: results of a Dutch prospective study. J Clin Oncol 8:287
13. Ravindranath Y, Yeager AM, Chang MN, Steuber CP, Krischer J, Graham-Pole J, Carroll A, Inoue S, Camitta B, Weinstein HJ (1996) Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group. N Engl J Med 334:1428
14. Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil K, Mohamed A, Chung A, Paietta E, Willman C, Head DR, Forman SF, Appelbaum FR (1998) Karyotypic analysis predicts outcome of pre- and post-remission therapy in adult acute myeloid leukemia (AML): a SWOG/ECOG Intergroup Study. Blood 92:678a
15. Stewart P, Buckner CD, Bensinger WI, Appelbaum FR, Fefer A, Clift R, Storb R, Sanders J, Thomas ED (1985) Autologous marrow transplantation in patients with acute non-lymphocytic leukemia in first remission. Exp Hematol 13:267
16. Tallman MS, Rowlings PA, Milone G, Zhang M-J, Perez WS, Weisdorf D, Keating A, Gale RP, Geller RB, Laughlin MJ, Lazarus HM, Luger SM, McCarthy PL, Rowe JM, Saex RA, Vowles MR, Horowitz MM (2000) Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission. Blood 96:1254
17. Watson M, Wheatley K, Harrison GA, Zittoun R, Gray RG, Goldstone AH, Burnett AK (1999) Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone. Cancer 86:1231
18. Wheatley K, Burnett AK, Goldstone AH, Gray RG, Hann IM, Harrison CJ, Rees JK, Stevens RF, Walker H (1999) A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties. Br J Haematol 107:69
19. Woods WG, Neudorf S, Gold S, Sanders J, Buckley JD, Barnard D, Dusenbery K, DeSwarte J, Arthur DC, Lange BJ, Kobrinsky N (2000) A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's Cancer Group. Blood 97:56
20. Zittoun RA, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L, Leoni F, Damasio E, Visani G, Papa G, Caronia F, Hayat M, Struckmans P, Rotoli B, Leoni P, Petermans ME, Dardenne M, Vegna ML, Petti MC, Solbu G, Suciu S (1995) Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 332:217
21. Zittoun R, Suciu S, Watson M, Solbu G, Muus P, Mandelli F, Stryckmans P, Peetermans M, Thaler J, Resegotti L, Dardenne M, Willemze R (1997) Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIEMEMA AML 8A trial. Bone Marrow Transplant 20:307